Microvascular angina: An update on diagnosis and treatment

Future Cardiology

Volumn 11, Issue 2, 2015, Pages 229-242

  Titterington, Jane S ^a   Hung, Olivia Y ^a   Wenger, Nanette K ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

coronary flow reserve; endothelial dysfunction; ischemic heart disease; microvascular angina; microvascular coronary dysfunction; nonobstructive coronary artery disease

Indexed keywords

AMLODIPINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NEBIVOLOL; RANOLAZINE;

ANGIOCARDIOGRAPHY; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR RISK; CLINICAL FEATURE; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; CORONARY ARTERY SPASM; CORONARY FLOW RESERVE; ENDOTHELIAL DYSFUNCTION; HEART CATHETERIZATION; HEART MUSCLE BLOOD FLOW; HEART MUSCLE ISCHEMIA; HUMAN; ISCHEMIC HEART DISEASE; LIFESTYLE MODIFICATION; MICROCIRCULATION; MYOCARDIAL PERFUSION IMAGING; NONCARDIAC CHEST PAIN; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SMOKING; SYNDROME X; TRANSTHORACIC ECHOCARDIOGRAPHY; VASODILATATION; MICROVASCULAR ANGINA; PATHOPHYSIOLOGY;

HUMANS; MICROVASCULAR ANGINA;

EID: 84924650677     PISSN: 14796678     EISSN: 17448298     Source Type: Journal    
DOI: 10.2217/fca.14.79     Document Type: Review

References (70)

1. Go AS, Mozaffarian D, Roger VL., et al. Heart disease and stroke statistics -2013 update: a report from the American Heart Association. Circulation 127(1), e6-e245 (2013
2. Velagaleti RS, Pencina MJ, Murabito JM., et al. Long-term trends in the incidence of heart failure after myocardial infarction. Circulation 118(20), 2057-2062 (2008
3. Bairey Merz CN, Kelsey SF, Pepine CJ., et al. The Women's Ischemia Syndrome Evaluation (WISE) study: protocol design, methodology and feasibility report. J. Am. Coll. Cardiol. 33(6), 1453-1461 (1999
4. Shaw LJ, Merz CN, Pepine CJ., et al. The economic burden of angina in women with suspected ischemic heart disease: results from the National Institutes of Health-National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation. Circulation 114(9), 894-904 (2006
5. Ong P, Athanasiadis A, Borgulya G, Mahrholdt H, Kaski JC, Sechtem U. High prevalence of a pathological response to acetylcholine testing in patients with stable angina pectoris and unobstructed coronary arteries. The ACOVA study (Abnormal COronary VAsomotion in patients with stable angina and unobstructed coronary arteries). J. Am. Coll. Cardiol. 59(7), 655-662 (2012
6. Shaw LJ, Shaw RE, Merz CN., et al. Impact of ethnicity and gender differences on angiographic coronary artery disease prevalence and in-hospital mortality in the American College of Cardiology-National Cardiovascular Data Registry. Circulation 117(14), 1787-1801 (2008
7. Jespersen L, Hvelplund A, Abildstrom SZ., et al. Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events. Eur. Heart J. 33(6), 734-744 (2012
8. Murthy VL, Naya M, Taqueti VR., et al. Effects of gender on coronary microvascular dysfunction and cardiac outcomes. Circulation 129(24), 2518-2527 (2014
9. Lanza GA, Crea F. Primary coronary microvascular dysfunction: clinical presentation, pathophysiology, and management. Circulation 121(21), 2317-2325 (2010
10. Kern MJ, Lerman A, Bech JW., et al. Physiological assessment of coronary artery disease in the cardiac catheterization laboratory: a scientific statement from the American Heart Association Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology. Circulation 114(12), 1321-1341 (2006
11. Kern MJ, Samady H. Current concepts of integrated coronary physiology in the catheterization laboratory. J. Am. Coll. Cardiol. 55(3), 173-185 (2010
12. Lotfi A, Jeremias A, Fearon WF., et al. Expert consensus statement on the use of fractional flow reserve, intravascular ultrasound, and optical coherence tomography: a consensus statement of the society of cardiovascular angiography and interventions. Catheter. Cardiovasc. Interv. 83(4), 509-518 (2014
13. Halcox JP, Schenke WH, Zalos G., et al. Prognostic value of coronary vascular endothelial dysfunction. Circulation 106(6), 653-658 (2002
14. Johnson BD, Shaw LJ, Buchthal SD., et al. Prognosis in women with myocardial ischemia in the absence of obstructive coronary disease: results from the National Institutes of Health-National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE). Circulation 109(24), 2993-2999 (2004
15. Lamendola P, Lanza GA, Spinelli A., et al. Long-term prognosis of patients with cardiac syndrome X. Int. J. Cardiol. 140(2), 197-199 (2010
16. Prinzmetal M, Kennamer R, Merliss R, Wada T, Bor N. Angina pectoris. I. A variant form of angina pectoris; preliminary report. Am. J. Med. 27, 375-388 (1959
17. Ohba K, Sugiyama S, Sumida H., et al. Microvascular coronary artery spasm presents distinctive clinical features with endothelial dysfunction as nonobstructive coronary artery disease. J. Am. Heart Assoc. 1(5), e002485 (2012
18. Flammer AJ, Anderson T, Celermajer DS., et al. The assessment of endothelial function: from research into clinical practice. Circulation 126(6), 753-767 (2012
19. Wenger NK. Angina in women. Curr. Cardiol. Rep. 12(4), 307-314 (2010
20. Lerner DJ, Kannel WB. Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am. Heart J. 111(2), 383-390 (1986
21. Pepine CJ, Abrams J, Marks RG, Morris JJ, Scheidt SS, Handberg E. Characteristics of a contemporary population with angina pectoris. TIDES Investigators. Am. J. Cardiol. 74(3), 226-231 (1994
22. Johnson BD, Shaw LJ, Pepine CJ., et al. Persistent chest pain predicts cardiovascular events in women without obstructive coronary artery disease: results from the NIH-NHLBI-sponsored Women's Ischaemia Syndrome Evaluation (WISE) study. Eur. Heart J. 27(12), 1408-1415 (2006
23. Radico F, Cicchitti V, Zimarino M, De Caterina R. Angina pectoris and myocardial ischemia in the absence of obstructive coronary artery disease: practical considerations for diagnostic tests. JACC Cardiovasc. Interv. 7(5), 453-463 (2014
24. Kurita T, Sakuma H, Onishi K., et al. Regional myocardial perfusion reserve determined using myocardial perfusion magnetic resonance imaging showed a direct correlation with coronary flow velocity reserve by Doppler flow wire. Eur. Heart J. 30(4), 444-452 (2009
25. Shufelt CL, Thomson LE, Goykhman P., et al. Cardiac magnetic resonance imaging myocardial perfusion reserve index assessment in women with microvascular coronary dysfunction and reference controls. Cardiovasc. Diagn. Ther. 3(3), 153-160 (2013
26. Task Force Members; Montalescot G, Sechtem U,Achenbach S , 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur. Heart J. 34(38), 2949-3003 (2013
27. Galiuto L, Sestito A, Barchetta S., et al. Noninvasive evaluation of flow reserve in the left anterior descending coronary artery in patients with cardiac syndrome X. Am. J. Cardiol. 99(10), 1378-1383 (2007
28. Voci P, Testa G, Plaustro G. Imaging of the distal left anterior descending coronary artery by transthoracic color-Doppler echocardiography. Am. J. Cardiol. 81(12A), 74G-78G (1998
29. Vogel R, Indermuhle A, Reinhardt J., et al. The quantification of absolute myocardial perfusion in humans by contrast echocardiography: algorithm and validation. J. Am. Coll. Cardiol. 45(5), 754-762 (2005
30. Cortigiani L, Rigo F, Gherardi S, Galderisi M, Bovenzi F, Sicari R. Prognostic meaning of coronary microvascular disease in Type 2 diabetes mellitus: a transthoracic Doppler echocardiographic study. J. Am. Soc. Echocardiol. 27(7), 742-748 (2014
31. Panting JR, Gatehouse PD, Yang GZ., et al. Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging. N. Engl. J. Med. 346(25), 1948-1953 (2002
32. Lanza GA, Buffon A, Sestito A., et al. Relation between stress-induced myocardial perfusion defects on cardiovascular magnetic resonance and coronary microvascular dysfunction in patients with cardiac syndrome X. J. Am. Coll. Cardiol. 51(4), 466-472 (2008
33. Yilmaz A, Athanasiadis A, Mahrholdt H., et al. Diagnostic value of perfusion cardiovascular magnetic resonance in patients with angina pectoris but normal coronary angiograms assessed by intracoronary acetylcholine testing. Heart 96(5), 372-379 (2010
34. Koo BK, Erglis A, Doh JH., et al. Diagnosis of ischemia-causing coronary stenoses by noninvasive fractional flow reserve computed from coronary computed tomographic angiograms. Results from the prospective multicenter DISCOVER-FLOW (Diagnosis of Ischemia-Causing Stenoses Obtained Via Noninvasive Fractional Flow Reserve) study. J. Am. Coll. Cardiol. 58(19), 1989-1997 (2011
35. Min JK, Leipsic J, Pencina MJ., et al. Diagnostic accuracy of fractional flow reserve from anatomic CT angiography. JAMA 308(12), 1237-1245 (2012
36. Norgaard BL, Leipsic J, Gaur S., et al. Diagnostic performance of noninvasive fractional flow reserve derived from coronary computed tomography angiography in suspected coronary artery disease: the NXT trial (Analysis of Coronary Blood Flow Using CT Angiography: Next Steps). J. Am. Coll. Cardiol. 63(12), 1145-1155 (2014
37. Inohara T, Kohsaka S, Miyata H., et al. Appropriateness ratings of percutaneous coronary intervention in Japan and its association with the trend of noninvasive testing. JACC Cardiovasc. Interv. 7(9), 1000-1009 (2014
38. Kimura T, Shiomi H, Kuribayashi S., et al. Cost analysis of non-invasive fractional flow reserve derived from coronary computed tomographic angiography in Japan. Cardiovasc. Interv. Ther. doi:10.1007/s12928-014-0285-1 (2014) (Epub ahead of print
39. Di Franco A, Lanza GA, Di Monaco A., et al. Coronary microvascular function and cortical pain processing in patients with silent positive exercise testing and normal coronary arteries. Am. J. Cardiol. 109(12), 1705-1710 (2012
40. Bottcher M, Botker HE, Sonne H, Nielsen TT, Czernin J. Endothelium-dependent and -independent Perfusion Reserve and the Effect of L-arginine on Myocardial Perfusion in Patients with Syndrome X. Circulation 99(14), 1795-1801 (1999
41. Inobe Y, Kugiyama K, Morita E., et al. Role of adenosine in pathogenesis of syndrome X: assessment with coronary hemodynamic measurements and thallium-201 myocardial single-photon emission computed tomography. J. Am. Coll. Cardiol. 28(4), 890-896 (1996
42. Kaufmann PA, Camici PG. Myocardial blood flow measurement by PET: technical aspects and clinical applications. J. Nucl. Med. 46(1), 75-88 (2005
43. Xu Y, Arora RC, Hiebert BM., et al. Non-invasive endothelial function testing and the risk of adverse outcomes: a systematic review and meta-analysis. Eur. Heart J. Cardiovasc. Imaging 15(7), 736-746 (2014
44. Eshtehardi P, Luke J, Mcdaniel MC, Samady H. Intravascular imaging tools in the cardiac catheterization laboratory: comprehensive assessment of anatomy and physiology. J. Cardiovasc. Transl. Res. 4(4), 393-403 (2011
45. Ludmer PL, Selwyn AP, Shook TL., et al. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N. Engl. J. Med. 315(17), 1046-1051 (1986
46. Penny WF, Rockman H, Long J., et al. Heterogeneity of vasomotor response to acetylcholine along the human coronary artery. J. Am. Coll. Caridol. 25(5), 1046-1055 (1995
47. Gibson CM, Cannon CP, Daley WL., et al. TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation 93(5), 879-888 (1996
48. Goel PK, Gupta SK, Agarwal A, Kapoor A. Slow coronary flow: a distinct angiographic subgroup in syndrome X. Angiology 52(8), 507-514 (2001
49. Hong HC, Lee DH, Lee SH, Joo SB. TIMI frame count versus thermodilution: diagnosing microvascular angina in cardiac syndrome X. Int. J. Cardiol. 157(1), 137-139 (2012
50. Tanedo JS, Kelly RF, Marquez M., et al. Assessing coronary blood flow dynamics with the TIMI frame count method: comparison with simultaneous intracoronary Doppler and ultrasound. Catheter. Cardiovasc. Interv. 53(4), 459-463 (2001
51. Manginas A, Gatzov P, Chasikidis C, Voudris V, Pavlides G, Cokkinos DV. Estimation of coronary flow reserve using the Thrombolysis In Myocardial Infarction (TIMI) frame count method. Am. J. Cardiol. 83(11), 1562-1565, A1567 (1999
52. Duvernoy CS. Evolving strategies for the treatment of microvascular angina in women. Expert Rev. Cardiovasc. Ther. 10(11), 1413-1419 (2012
53. Erdamar H, Sen N, Tavil Y., et al. The effect of nebivolol treatment on oxidative stress and antioxidant status in patients with cardiac syndrome-X. Coron. Artery Dis. 20(3), 238-244 (2009
54. Kayaalti F, Kalay N, Basar E., et al. Effects of nebivolol therapy on endothelial functions in cardiac syndrome X. Heart Vessels 25(2), 92-96 (2010
55. Pauly DF, Johnson BD, Anderson RD., et al. In women with symptoms of cardiac ischemia, nonobstructive coronary arteries, and microvascular dysfunction, angiotensin-converting enzyme inhibition is associated with improved microvascular function: a double-blind randomized study from the National Heart, Lung and Blood Institute Women's Ischemia Syndrome Evaluation (WISE). Am. Heart J. 162(4), 678-684 (2011
56. Bavry AA, Handberg EM, Huo T., et al. Aldosterone inhibition and coronary endothelial function in women without obstructive coronary artery disease: an ancillary study of the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation. Am. Heart J. 167(6), 826-832 (2014
57. Lerman A, Burnett JC Jr, Higano ST, McKinley LJ, Holmes DR Jr. Long-term L-arginine supplementation improves small-vessel coronary endothelial function in humans. Circulation 97(21), 2123-2128 (1998
58. Russo G, Di Franco A, Lamendola P., et al. Lack of effect of nitrates on exercise stress test results in patients with microvascular angina. Cardiovasc. Drugs Ther. 27(3), 229-234 (2013
59. Chaitman BR, Pepine CJ, Parker JO., et al. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial. JAMA 291(3), 309-316 (2004
60. Chaitman BR, Skettino SL, Parker JO., et al. Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina. J. Am. Coll. Cardiol. 43(8), 1375-1382 (2004
61. Stone PH, Gratsiansky NA, Blokhin A, Huang IZ, Meng L, Investigators E. Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (Efficacy of Ranolazine in Chronic Angina) trial. J. Am. Coll. Cardiol. 48(3), 566-575 (2006
62. Morrow DA, Scirica BM, Karwatowska-Prokopczuk E., et al. Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial. JAMA 297(16), 1775-1783 (2007
63. Mehta PK, Goykhman P, Thomson LE., et al. Ranolazine improves angina in women with evidence of myocardial ischemia but no obstructive coronary artery disease. JACC Cardiovasc. Imaging 4(5), 514-522 (2011
64. Eckel RH, Jakicic JM, Ard JD., et al. 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 129(25 Suppl. 2), S76-S99 (2014
65. Boden WE, Franklin B, Berra K., et al. Exercise as a therapeutic intervention in patients with stable ischemic heart disease: an underfilled prescription (narrative review). Am. J. Med. 127(10), 905-911 (2014
66. Hambrecht R, Wolf A, Gielen S., et al. Effect of exercise on coronary endothelial function in patients with coronary artery disease. N. Engl. J. Med. 342(7), 454-460 (2000
67. Eriksson BE, Tyni-Lenne R, Svedenhag J., et al. Physical training in syndrome X: physical training counteracts deconditioning and pain in syndrome X. J. Am. Coll. Cardiol. 36(5), 1619-1625 (2000
68. Carvalho EE, Crescencio JC, Elias J Jr, Brito LB, Gallo L Jr, Simoes MV. Improved endothelial function and reversal of myocardial perfusion defects after aerobic physical training in a patient with microvascular myocardial ischemia. Am. J. Phys. Med. Rehabil. 90(1), 59-64 (2011
69. Sugiishi M, Takatsu F. Cigarette smoking is a major risk factor for coronary spasm. Circulation 87(1), 76-79 (1993
70. Puranik R, Celermajer DS. Smoking and endothelial function. Prog. Cardiovasc. Dis. 45(6), 443-458 (2003